MapLight Therapeutics, Inc. MPLT
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.09M | 37.79M | 30.73M | 14.04M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 242.93M | 210.04M | 169.08M | 108.48M | -- |
| Operating Income | -242.93M | -210.04M | -169.08M | -108.48M | -- |
| Income Before Tax | -229.83M | -199.48M | -161.15M | -102.83M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -229.83 | -199.48 | -161.15 | -102.83 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -229.83M | -199.48M | -161.15M | -102.83M | -- |
| EBIT | -242.93M | -210.04M | -169.08M | -108.48M | -- |
| EBITDA | -242.34M | -209.47M | -168.50M | -107.85M | -- |
| EPS Basic | -42.32 | -80.11 | -108.11 | -133.58 | -- |
| Normalized Basic EPS | -26.49 | -50.11 | -67.80 | -84.03 | -- |
| EPS Diluted | -42.32 | -80.11 | -108.11 | -133.58 | -- |
| Normalized Diluted EPS | -26.49 | -50.11 | -67.80 | -84.03 | -- |
| Average Basic Shares Outstanding | 123.65M | 78.98M | 34.46M | 3.08M | -- |
| Average Diluted Shares Outstanding | 123.65M | 78.98M | 34.46M | 3.08M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |